Clinical Trials List
Protocol NumberSGT53-02-1
2016-09-01 - 2021-12-31
Phase II
ICD-10C25.9
Malignant neoplasm of pancreas, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9157.9
Malignant neoplasm of pancreas, part unspecified
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
28 participants
